Search
Generic filters
Search
Generic filters
Search
Generic filters
Search
Generic filters

News from
Science, Economy
and the BIO.NRW network

News

RheinCell Therapeutics Achieves Milestone GMP Certification to Manufacture Cord Blood-Derived iPSCs for Safe and Compliant Cell Therapies

RheinCell Therapeutics Achieves Milestone GMP Certification to Manufacture Cord Blood-Derived iPSCs for Safe and Compliant Cell Therapies

RheinCell Therapeutics GmbH, a developer and manufacturer of human induced pluripotent stem cells (iPSCs) as starting materials for cell therapies, announced it has received Good Manufacturing Practice (GMP) certification and Manufacturing Authorization ...
Weiterlesen …
BIO.NRW establishes the new focus area BIO.NRW.eco

BIO.NRW establishes the new focus area BIO.NRW.eco

In recent years, issues such as climate change, finite resources and a growing world population have increasingly become the focus of society and politics. To meet the challenges of our time, innovative ...
Weiterlesen …
The new issue of "Spot on Biotechnology Business" is out!

The new issue of “Spot on Biotechnology Business” is out!

For the 11th time, BIO.NRW is publishing the brochure "Spot on Biotechnology Business". As usual, BIO.NRW presents an analysis of the local industry and provides facts and figures on biotechnology in NRW ...
Weiterlesen …
Bioeconomy now with more visibility on our BIO.NRW homepage!

Bioeconomy now with more visibility on our BIO.NRW homepage!

Definitions, backgrounds, specific funding tools and relevance for NR is discussed. The bioeconomy now has its own tab on the BIO.NRW homepage ...
Weiterlesen …
New Bioeconomy Council convenes for its constituent meeting

New Bioeconomy Council convenes for its constituent meeting

The Federal Ministry of Education and Research (BMBF) and the Federal Ministry of Food and Agriculture (BMEL) have appointed the members of the new Bioeconomy Council. They met in digital form on ...
Weiterlesen …
AiCuris receives approval from BfArM to initiate Compassionate Use Program for Pritelivir in Germany

AiCuris receives approval from BfArM to initiate Compassionate Use Program for Pritelivir in Germany

The Compassionate Use Program (CUP) may provide access to pritelivir for use in immunocompromised patients that have acyclovir-resistant mucocutaneous herpes simplex virus infections and foscarnet resistance or intolerance CUPs offer a method ...
Weiterlesen …
EuropaBio Webinar: The European Commission’s Toolbox for Biotech SMEs & Start-Ups

EuropaBio Webinar: The European Commission’s Toolbox for Biotech SMEs & Start-Ups

The Webinare is part of a series by EuropaBio on  "How does the EU support small – and medium sized biotech?" Wednesday, December 9, 2020 2:00 pm - 3:30 pm Europe Time ...
Weiterlesen …
InfanDx completes two-year follow-up study AAMBI2 of newborns with suspected perinatal asphyxia

InfanDx completes two-year follow-up study AAMBI2 of newborns with suspected perinatal asphyxia

InfanDx AG, a diagnostics company specialized in the development of biomarker-based tests, today announced the completion of recruitment for its two-year follow-up study AAMBI2 (Asphyxia Associated Metabolite Biomarker Investigation 2). The study ...
Weiterlesen …

News archive

Positive interim phase 1/2a data on Janssen's COVID19 vaccine candidate.

Positive interim phase 1/2a data on Janssen’s COVID19 vaccine candidate.

The New England Journal of Medicine (NEJM) has published interim phase 1/2a data for Janssen's Covid19 vaccine candidate. They show ...
Weiterlesen …
DiosCURE to Develop Highly Specific Single-Chain Antibodies Against SARS-CoV-2

DiosCURE to Develop Highly Specific Single-Chain Antibodies Against SARS-CoV-2

Core technology includes promising bivalent single-domain antibodies simultaneously targeting two surface structures of the viral spike protein. Lead candidates DIOS-202 ...
Weiterlesen …
RheinCell Therapeutics Achieves Milestone GMP Certification to Manufacture Cord Blood-Derived iPSCs for Safe and Compliant Cell Therapies

RheinCell Therapeutics Achieves Milestone GMP Certification to Manufacture Cord Blood-Derived iPSCs for Safe and Compliant Cell Therapies

RheinCell Therapeutics GmbH, a developer and manufacturer of human induced pluripotent stem cells (iPSCs) as starting materials for cell therapies, ...
Weiterlesen …
BIO.NRW establishes the new focus area BIO.NRW.eco

BIO.NRW establishes the new focus area BIO.NRW.eco

In recent years, issues such as climate change, finite resources and a growing world population have increasingly become the focus ...
Weiterlesen …
Bioeconomy now with more visibility on our BIO.NRW homepage!

Bioeconomy now with more visibility on our BIO.NRW homepage!

Definitions, backgrounds, specific funding tools and relevance for NR is discussed. The bioeconomy now has its own tab on the ...
Weiterlesen …
New Bioeconomy Council convenes for its constituent meeting

New Bioeconomy Council convenes for its constituent meeting

The Federal Ministry of Education and Research (BMBF) and the Federal Ministry of Food and Agriculture (BMEL) have appointed the ...
Weiterlesen …
AiCuris receives approval from BfArM to initiate Compassionate Use Program for Pritelivir in Germany

AiCuris receives approval from BfArM to initiate Compassionate Use Program for Pritelivir in Germany

The Compassionate Use Program (CUP) may provide access to pritelivir for use in immunocompromised patients that have acyclovir-resistant mucocutaneous herpes ...
Weiterlesen …
EuropaBio Webinar: The European Commission’s Toolbox for Biotech SMEs & Start-Ups

EuropaBio Webinar: The European Commission’s Toolbox for Biotech SMEs & Start-Ups

The Webinare is part of a series by EuropaBio on  "How does the EU support small – and medium sized ...
Weiterlesen …
No posts found.
No posts found.
No posts found.